Active, Not Recruiting
Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
NCT04537156
- Conditions
- Cervical Cancer, Cervical Intraepithelial Neoplasia, Communicable Diseases, +31 more
- Locations
-
- Jiangsu Provincial Centre for Disease Control and Prevention Nanjing, Jiangsu, China
- Sichuan Provincial Centre for Disease Control and Prevention Chengdu, Sichuan, China